Board

​Gill Eapen, MS, MBA, CFA

Over three decades of experience in finance, economics, planning and management. Previous employers include Pfizer, HP, Deloitte, and ABB. Consulting clients in various industries including life-sciences, hi-technology, aerospace, manufacturing, financial services & healthcare.
MBA, University of Chicago
MS, Northwestern University
B. Tech, Indian Institute of Technology
​CFA Charter holder.

Craig Saxton, MD, PhD

Over 3 decades of experience in guiding large scale Research and Development. Retired Executive Vice President, Pfizer. Member of the board of directors of Tularik , Neurogen and Veritas Medicine. Graduated in medicine from the University of Leeds in 1965. Pursued research in Cardiovascular disease and applied physiology from 1966 until joining Pfizer in 1976.

​

Advisory Board

Dr. Pierre Etienne, MD
Over 2 decades of experience in early clinical research and development operations. Previous employers include CIBA-Geigy (Novartis), Pfizer, PhageTech and Targanta Therapeutics (TARG) where he served first as CEO from June 2003 to September 2006 and Chief Development Officer until December 2008. Graduated in medicine from Université de Liège (Belgium) in 1972. Pursued research in Alzheimer’s disease at McGill University from 1976 until joining CIBA-Geigy in 1983.

---

Dr. Ian Williams, PhD
Over 2 decades of R&D experience in Pharma culminating in heading a large research department for 4 years. 6 years experience in global strategic planning for Pfizer with an emphasis in ethics, future scenarios, and assessment of R&D performance. Board member of Vion Pharmaceuticals. Pittsburgh, PA. Research fellow at Rockefeller, D. Phil.– the University of Oxford, B. Sc.-University of Bristol.

---

Dr. David Dresback, PhD
Over 27 years of experience in developing and managing the development of conventional and novel dosage forms and evaluating and sourcing new drug delivery technology and partners.  Retired Senior Director-Pfizer. B.S Pharmacy and Ph.D. Pharmaceutical Chemistry, University of Michigan.

---

Dr. Ralph Stevenson, PhD
11 years of experience in academia performing research in the areas of diabetes and osteoporosis followed by 21 years management experience in Research and Development at Pfizer with oversight of diabetes, obesity, and metabolic syndrome. Ph.D. in Pharmacology, Glasgow University, U.K.

---

Dr. Mak Jawadekar, PhD
Over three decades of experience in Formulations, Drug product R & D, Drug Delivery Systems, Clinical Trials Supply Manufacturing, Commercial Pharma drug Product Mfg, Technology Transfer, Preclinical, Clinical and commercial dosage form development. Member of the Board of Directors on Just One Break, NY based non-profit org. Member of the Strategic Advisory Committee of Bilcare, European Pharm Tech, Contract Pharma, Ph.D. in Pharmaceutics from the University of Minnesota.

---

Mr. Jim Schoeck, MBA, MHS
Over 30 years of experience in healthcare management; 10 years in Hospital/System Administration and 20+years as an entrepreneur in physician practice management.  Jim has been involved in the formation of large primary care-based organizations focused on the effective delivery of care and the assumption of risk.  MBA and Master of Health Sciences from the University of Florida. ​

---

Mr. Dennis O'Donnell, MHA, PT
More than 30 years’ experience in healthcare as a clinician, health system executive, and technology company CEO. Passionate about the application of evidence, technology, and human-centered design to improve value. B.S. in Physical Therapy from the University of Wisconsin and MHA from the University of Minnesota.

---

Mr. Ejaz Elahi, MBA
Over 20 years of experience in healthcare investment banking and consulting.  Helping providers, payers and life sciences companies develop and execute long-term growth strategies in the evolving healthcare landscape.  MBA from the University of Chicago.

---

Mr. Joseph Hoffman, MBA, CFA, CLU
Over 30 years of experience in insurance and financial services, including 9 years as CFO of Central Benefits Mutual Insurance Company, a national health insurer and parent company of one of the largest healthcare TPA’s in the U.S.  He also spent 8 years as CEO of United Commercial Travelers, an international life, and health insurer. 

---

Dr. Alan Fine, MD   
Over three decades of experience in private practice of Obstetrics and Gynecology. Currently a Principal Investigator for Shionogi, Inc, and Allergan, Inc.  Consultant for Amgen, Inc and Shionogi, Inc in fields of Osteoporosis and menopausal medicine. Ob/Gyn Pharmacy and Therapeutics board member for Connecticare, Inc.

---

Ms. Aileen Leventon, MBA, JD
40 Years of experience with leading law firms, alternate legal service providers and corporate legal departments to add value to their clients and firms by harnessing data. MBA from Columbia University, JD from Cornell University, and BA, Phi Beta Kappa from Stony Brook University.​

---

Mr. Frank P Orlowski, MBA
25 Year Pfizer Finance Executive responsible for 35 markets in Asia, Eastern Europe, The Middle East, and South America. Retired. Leveraged RPA for Compliance and Control Programs as well as Manufacturing Automation. Board Member of The American Cancer Society.

---

Mr. Warren Agin, JD
Over 25 years experience representing debtors, creditors and bankruptcy trustees in insolvency matters. Founder of Analytic Law and an adjunct professor at Boston College Law School; a leader in applying analytics to legal problems.

---

Mr. Charles Dykes
Over 20 years of experience in high tech and business-led, technology-enabled innovation. Business strategist and trusted advisor specializing in Artificial Intelligence and deep learning technology. Recent certification in AI and Implications for Business Strategy from MIT Sloan School of Management.